Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · IEX Real-Time Price · USD
5.90
-0.14 (-2.32%)
Jul 19, 2024, 4:30 PM EDT - Market closed
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $326.44 million as of July 22, 2024. Its market cap has increased by 14.46% in one year.
Market Cap
326.44M
Enterprise Value
161.05M
1-Year Change
14.46%
Ranking
Category
Stock Price
$5.90
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $326.44M, a decrease of -42.27%. That is a compound annual growth rate of -13.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 251.30M | -7.71% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.30M | 16.86% |
| Dec 31, 2020 | 725.90M | 28.38% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kamada | 332.20M |
| ADC Therapeutics | 331.02M |
| Inozyme Pharma | 329.69M |
| Nautilus Biotechnology | 326.94M |
| XOMA Corporation | 326.58M |
| Spok Holdings | 325.55M |
| Black Diamond Therapeutics | 323.45M |
| Amarin Corporation | 322.35M |